We are live on ! Find out more
CS

Candriam SCA Portfolio holdings

AUM $19.3B
1-Year Est. Return 39.18%
This Fund
S&P 500
This Quarter Est. Return
+4.05%
1 Year Est. Return
+39.18%
3 Year Est. Return
+109.85%
5 Year Est. Return
+149.31%
10 Year Est. Return
+617.16%
AUM
$6.32B
AUM Growth
+$456M
Cap. Flow
+$224M
Cap. Flow %
3.55%
Top 10 Hldgs %
17.62%
Holding
844
New
72
Increased
349
Reduced
257
Closed
60

Top Buys

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$37.6M
2
BMY icon
Bristol-Myers Squibb
BMY
+$29.3M
3
BIIB icon
Biogen
BIIB
+$27.4M
4
HD icon
Home Depot
HD
+$22.7M
5
CSCO icon
Cisco
CSCO
+$21.1M

Top Sells

Rank Stock Value
1
JPM icon
JPMorgan Chase
JPM
+$23.6M
2
TJX icon
TJX Companies
TJX
+$19.3M
3
FDX icon
FedEx
FDX
+$16.4M
4
INTU icon
Intuit
INTU
+$14.7M
5
GLW icon
Corning
GLW
+$13.3M

Sector Composition

Rank Sector Weight
1 Healthcare 25.18%
2 Technology 17.19%
3 Financials 12.85%
4 Consumer Discretionary 10.2%
5 Communication Services 8.65%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DELL icon
451
Dell
DELL
$283B
$2.2M 0.03%
92,662
-5,199
-5% -$115K
BBY icon
452
Best Buy
BBY
$18B
$2.19M 0.03%
29,429
+1,095
+4% +$80.9K
IEX icon
453
IDEX
IEX
$16.5B
$2.19M 0.03%
16,062
+405
+3% +$56.6K
NOV icon
454
NOV
NOV
$7.45B
$2.15M 0.03%
49,590
-343
-0.7% -$13.9K
IQV icon
455
IQVIA
IQV
$34.7B
$2.14M 0.03%
21,447
+2,249
+12% +$225K
SRRA
456
DELISTED
Sierra Oncology, Inc. Common Stock
SRRA
$2.13M 0.03%
18,000
– –
XEL icon
457
Xcel Energy
XEL
$51B
$2.12M 0.03%
46,404
-18,113
-28% -$811K
CNC icon
458
Centene
CNC
$31.3B
$2.11M 0.03%
34,262
-132,484
-79% -$7.64M
ANSS
459
DELISTED
Ansys
ANSS
$2.08M 0.03%
+11,957
New +$1.99M
SYRS
460
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$2.08M 0.03%
20,400
– –
ANDV
461
DELISTED
Andeavor
ANDV
$2.08M 0.03%
15,869
-8,858
-36% -$1.17M
MCK icon
462
McKesson
MCK
$98.5B
$2.07M 0.03%
15,539
+1,320
+9% +$193K
MTD icon
463
Mettler-Toledo International
MTD
$26.8B
$2.07M 0.03%
3,579
-33
-0.9% -$18.8K
GPN icon
464
Global Payments
GPN
$22.1B
$2.05M 0.03%
18,422
+8,710
+90% +$984K
LPT
465
DELISTED
Liberty Property Trust
LPT
$2.03M 0.03%
45,891
+16,594
+57% +$703K
SLF icon
466
Sun Life Financial
SLF
$45.6B
$2.03M 0.03%
50,515
-12,421
-20% -$514K
ACAD icon
467
Acadia Pharmaceuticals
ACAD
$4.25B
$2.02M 0.03%
132,000
+55,000
+71% +$981K
IMVP
468
Invesco India ETF
IMVP
$122M
$2.02M 0.03%
82,000
-13,000
-14% -$325K
GHDX
469
DELISTED
Genomic Health, Inc.
GHDX
$2.02M 0.03%
40,000
-34,000
-46% -$1.35M
FMC icon
470
FMC
FMC
$1.42B
$2M 0.03%
25,833
-74,945
-74% -$5.56M
TWTR
471
DELISTED
Twitter, Inc.
TWTR
$1.98M 0.03%
45,411
-1,300
-3% -$45.6K
ATO icon
472
Atmos Energy
ATO
$29.9B
$1.97M 0.03%
21,877
+15,557
+246% +$1.35M
PPL
473
PPL Corp
PPL
$27.3B
$1.97M 0.03%
68,901
+23,768
+53% +$658K
BXP icon
474
Boston Properties
BXP
$11B
$1.94M 0.03%
15,483
+513
+3% +$62.2K
PBA icon
475
Pembina Pipeline
PBA
$29.9B
$1.94M 0.03%
55,916
+3,415
+7% +$114K
17 18
19
20 21

Similar funds

PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
A
AustralianSuper Melbourne, Australia $19.2B AUM 31.95% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
LF
Lansforsakringar Fondforvaltning Stockholm, Sweden $19.1B AUM 26.9% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return
SOMRS
State of Michigan Retirement System Lansing, Michigan $18.9B AUM 27.96% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $18.9B AUM 18.9% 1-Year Est. Return
MIM
MetLife Investment Management Whippany, New Jersey $19.6B AUM 32.64% 1-Year Est. Return

Candriam SCA's Q2 2018 Portfolio in Review

As of Q2 2018, Candriam SCA held 844 positions worth $6.32B, up 7.8% from $5.86B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Candriam SCA deployed $224M of net new capital in Q2 2018, opening 72 new positions and adding to 349 existing holdings. Its largest new stake was Broadcom: 1,532,450 shares worth $37.2M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 23% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was JPMorgan Chase, an estimated $23.6M trimmed.

  • Candriam SCA's largest Q2 2018 buy was Broadcom: 1,532,450 shares worth $37.2M.
  • Candriam SCA added most to Bristol-Myers Squibb in Q2 2018, an estimated $29.3M increase.
  • Candriam SCA's biggest Q2 2018 reduction was JPMorgan Chase, cutting an estimated $23.6M.
  • Candriam SCA fully exited Monsanto Co in Q2 2018, selling an estimated $11.5M.
  • Candriam SCA's ten largest holdings make up 18% of its $6.32B portfolio in Q2 2018.
  • Candriam SCA opened 72 new positions and closed 60 in Q2 2018.
  • Candriam SCA's portfolio value rose 7.8% quarter-over-quarter to $6.32B.

Based on Candriam SCA's 13F filing for Q2 2018, filed 14 Aug 2018.